Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2020, Scientia Ventures is a New York-based venture capital firm specializing in early to mid-stage investments in the life sciences sector. The firm focuses on computational biology, digitization of medicine, and digital therapies, with a portfolio that includes notable companies like Royalty Pharma and ADC Therapeutics. Scientia Ventures emphasizes building new companies around identified innovations and partnering with existing firms to accelerate growth.
Scientia Ventures invests in pre-seed to Series B companies within the biotech and healthcare sectors. Their strategy includes building new ventures around breakthrough innovations and collaborating with established firms to enhance growth and commercialization. The firm targets investments in computational biology, digital therapies, and traditional drug development.
Notable portfolio companies include Royalty Pharma, a leader in pharmaceutical royalties; ADC Therapeutics, focused on antibody drug conjugates for cancer treatment; and Intra-Cellular Therapies, founded by Nobel Prize winner Paul Greengard. Other significant investments include FibroGen, Cibus, and Enterin, which are involved in innovative healthcare solutions.
Submit your pitch through their form at scientiavc.com or email info@scientiavc.com with your deck.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.